找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatitis C: Epidemiology, Prevention and Elimination; Volume 1 Angelos Hatzakis Book 2021 Springer Nature Switzerland AG 2021 pathogenesis

[復(fù)制鏈接]
樓主: Embolism
41#
發(fā)表于 2025-3-28 14:48:26 | 只看該作者
42#
發(fā)表于 2025-3-28 21:50:53 | 只看該作者
Laboratory Diagnosis,ection of HCV RNA to confirm an active infection. Assays that detect and quantify HCV core antigen provide an alternative to testing for HCV RNA. Molecular assays to quantify the HCV RNA load, determine the HCV genotype, and detect drug resistance-associated mutations are established in well-resourc
43#
發(fā)表于 2025-3-29 02:40:30 | 只看該作者
44#
發(fā)表于 2025-3-29 03:59:38 | 只看該作者
45#
發(fā)表于 2025-3-29 10:34:58 | 只看該作者
Natural History of Hepatitis C Infection,tive antiviral treatments allowed observational studies of large untreated cohorts. However, deep understanding of HCV natural history has been always hampered by the asymptomatic course of the disease, both in the acute and in the chronic infection phase. As a consequence, many studies conducted in
46#
發(fā)表于 2025-3-29 12:35:51 | 只看該作者
Epidemiology: Modeling of Natural History,hree important ingredients: disease stages, allowed transitions between stages, and corresponding stage-specific transition probabilities. This chapter reviews the approaches that have been used to model the natural history of chronic hepatitis C (CHC). A commonly used approach is to consider diseas
47#
發(fā)表于 2025-3-29 17:22:52 | 只看該作者
48#
發(fā)表于 2025-3-29 21:46:44 | 只看該作者
Hepatitis C Elimination and Advocacy Groups, of hepatitis C on the global public health agenda and resulted in the commitment by 193 countries to eliminate hepatitis C by 2030; and advocacy for viral hepatitis at a global level really began at a meeting of patient representatives from around the world in Barcelona in 2007.
49#
發(fā)表于 2025-3-30 03:01:03 | 只看該作者
HCV Elimination in Australia,d 1990s, followed by a decline in early- to mid-2000s, initially related to reduced heroin supply [1]. Ongoing HCV incidence of several 1000 infections/year over the last decade has been despite high-coverage harm-reduction services for people who inject drugs (PWID) [2].
50#
發(fā)表于 2025-3-30 04:28:33 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 03:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
静乐县| 任丘市| 滕州市| 禹州市| 辰溪县| 皮山县| 搜索| 辽宁省| 涪陵区| 曲麻莱县| 肥乡县| 策勒县| 茂名市| 西乌珠穆沁旗| 吉水县| 塘沽区| 长武县| 共和县| 汝州市| 忻州市| 依兰县| 富蕴县| 遵化市| 峨眉山市| 龙门县| 天长市| 延安市| 濮阳县| 通化市| 永州市| 淮南市| 江川县| 克山县| 南康市| 黄平县| 高邮市| 甘洛县| 桂阳县| 固始县| 嘉鱼县| 西华县|